Insmed
INSM
#640
Rank
NZ$65.42 B
Marketcap
NZ$306.75
Share price
3.35%
Change (1 day)
161.61%
Change (1 year)

Insmed (INSM) Fails to deliver data

Key failure to deliver metrics for Insmed:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Insmed (INSM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Insmed (INSM) - since 2013

Volume in USD (price x number of shares), data since 2013

Insmed (INSM) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$54.78 M37.02%
2024NZ$39.98 M264.99%
2023NZ$10.95 M15.72%
2022NZ$9.46 M-28.5%
2021NZ$13.23 M29.75%
2020NZ$10.2 M-74.29%
2019NZ$39.68 M48.24%
2018NZ$26.76 M204.1%
2017NZ$8.8 M123.23%
2016NZ$3.94 M-32.13%
2015NZ$5.8 M-38.86%
2014NZ$9.5 M211.03%
2013NZ$3.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sarepta Therapeutics
SRPT
NZ$2.06 MNZ$19.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$49.62 MNZ$0.10 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$35.08 MNZ$0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$6.44 MNZ$41.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/ANZ$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$47.76 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA